DIFFERENTIAL TREATMENT EFFECTS OF EXTENDED-RELEASE NIACIN AND PLACEBO ON BASELINE AND ONE-YEAR LIPOPROTEIN SUBFRACTIONS AND THEIR RELATIONSHIP TO CARDIOVASCULAR OUTCOMES: POST HOC SUBSET ANALYSIS OF AIM-HIGH TRIAL PATIENTS WITH HIGH TRIGLYCERIDE AND LOW HDL-C

被引：1
|
作者：
Toth, Peter P.
Jones, Steven
Slee, April
Marcovina, Santica
Fleg, Jerome
Boden, William
机构：
[1] CGH Med Ctr, Sterling, IL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)32131-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1140-104
引用
下载
收藏
页码：2130 / 2130
页数：1
相关论文
共 9 条
  • [1] ASSOCIATION BETWEEN BASELINE LIPOPROTEIN SUBFRACTIONS AND OUTCOMES IN PATIENTS WITH HIGH TRIGLYCERIDE AND LOW HDL-CHOLESTEROL LEVELS: A POST HOC SUBGROUP ANALYSIS OF THE AIM-HIGH TRIAL
    Toth, Peter P.
    Jones, Steven
    Slee, April
    Fleg, Jerome
    Marcovina, Santica
    Boden, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2000 - 2000
  • [2] Comparison of Extended-Release Niacin versus Placebo in Statin-Treated Patients With Low Baseline Levels of HDL-C and Well-Controlled on-Treatment LDL-C: Extended One-Year Follow-Up Outcomes From AIM-HIGH
    Probstfield, Jeffrey L.
    Boden, William E.
    McBride, Ruth
    Desvigne-Nickens, Patrice
    Fleg, Jerome
    Anderson, Todd
    Kashyap, Moti
    CIRCULATION, 2013, 128 (22)
  • [3] Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial
    Kalil, Roberto S.
    Wang, Jeffrey H.
    de Boer, Ian H.
    Mathew, Roy O.
    Ix, Joachim H.
    Asif, Arif
    Shi, Xuefeng
    Boden, William E.
    KIDNEY INTERNATIONAL, 2015, 87 (06) : 1250 - 1257
  • [4] EFFECTS OF EXTENDED-RELEASE NIACIN ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS AND CLINICAL OUTCOMES IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE AND LOW BASELINE LEVELS OF HDL-CHOLESTEROL: POST HOC ANALYSIS OF THE AIM HIGH TRIAL
    Lyubarova, Radmila
    Marcovina, Santica
    Fleg, Jerome
    Nickens, Patrice Desvigne
    Topliceanu, Alexandru
    Yao, Yao
    McBride, Ruth
    Boden, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2080 - 2080
  • [5] Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial
    Toth, Peter P.
    Jones, Steven R.
    Slee, April
    Fleg, Jerome
    Marcovina, Santica M.
    Lacy, Megan
    McBride, Ruth
    Boden, William E.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (03) : 741 - 747
  • [6] Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial
    Lyubarova, Radmila
    Albers, John J.
    Marcovina, Santica M.
    Yao, Yao
    McBride, Ruth
    Topliceanu, Alexandru
    Anderson, Todd
    Fleg, Jerome L.
    Desvigne-Nickens, Patrice
    Kashyap, Moti L.
    McGovern, Mark E.
    Boden, William E.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 534 - 541
  • [7] Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) Trial
    Teo, Koon K.
    Goldstein, Larry B.
    Chaitman, Bernard R.
    Grant, Shannon
    Weintraub, William S.
    Anderson, David C.
    Sila, Cathy A.
    Cruz-Flores, Salvador
    Padley, Robert J.
    Kostuk, William J.
    Boden, William E.
    STROKE, 2013, 44 (10) : 2688 - 2693
  • [8] Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes)
    Albers, John J.
    Slee, April
    O'Brien, Kevin D.
    Robinson, Jennifer G.
    Kashyap, Moti L.
    Kwiterovich, Peter O., Jr.
    Xu, Ping
    Marcovina, Santica M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) : 1575 - 1579
  • [9] The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial
    McBride, Ruth
    AMERICAN HEART JOURNAL, 2011, 161 (03) : 538 - 543
1